NICE Is A 2024 Gartner Peer Insights CCaaS Customers Choice Only Vendor to Receive This Recognition for the 2nd Time

NICE Stock  USD 179.84  2.67  1.46%   
About 62% of Nice's investor base is looking to short. The analysis of the overall prospects from investing in Nice Ltd ADR suggests that many traders are, at the present time, alarmed. The current market sentiment, together with Nice's historical and current headlines, can help investors time the market. In addition, many technical investors use Nice Ltd ADR stock news signals to limit their universe of possible portfolio assets.
  
NICE today announced that it was the only vendor named a Customers Choice in the 2024 Gartner Peer Insights Voice of the Customer for

Read at businesswire.com
businesswire News
  

Nice Fundamental Analysis

We analyze Nice's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nice using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nice based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Gross Profit

Gross Profit Comparative Analysis

Nice is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Nice Ltd ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nice stock to make a market-neutral strategy. Peer analysis of Nice could also be used in its relative valuation, which is a method of valuing Nice by comparing valuation metrics with similar companies.

Complementary Tools for Nice Stock analysis

When running Nice's price analysis, check to measure Nice's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nice is operating at the current time. Most of Nice's value examination focuses on studying past and present price action to predict the probability of Nice's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nice's price. Additionally, you may evaluate how the addition of Nice to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stocks Directory
Find actively traded stocks across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings